propagermanium has been researched along with Carcinoma, Ehrlich Tumor in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Suzuki, F | 4 |
Brutkiewicz, RR; Pollard, RB; Suzuki, F | 1 |
Aso, H; Ebina, T; Inoue, H; Ishida, N; Nakamura, T; Shibuya, E; Suzuki, F | 1 |
6 other study(ies) available for propagermanium and Carcinoma, Ehrlich Tumor
Article | Year |
---|---|
[Antitumor mechanisms of carboxyethyl-germanium sesquioxide (Ge-132) in mice bearing Ehrlich ascites tumors].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cytotoxicity, Immunologic; Female; Germanium; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Organometallic Compounds; Propionates | 1987 |
[Antitumor activity of Ge-132, a new organogermanium compound, in mice is expressed through the functions of macrophages and T lymphocytes].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Germanium; Leukemia; Liver Neoplasms, Experimental; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Organometallic Compounds; Propionates; T-Lymphocytes | 1985 |
Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours.
Topics: Animals; Carcinoma, Ehrlich Tumor; Dose-Response Relationship, Immunologic; Female; Germanium; Interferon-gamma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms, Experimental; Organometallic Compounds; Propionates; Time Factors | 1985 |
[Ability of sera from mice treated with Ge-132, an organo-germanium compound, to inhibit experimental murine ascites tumors].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Germanium; Immunization, Passive; Interferon-gamma; Leukemia, Experimental; Macrophage Activation; Mice; Mice, Inbred BALB C; Organometallic Compounds; Propionates | 1985 |
[Suppression of tumor growth by peritoneal macrophages isolated from mice treated with carboxyethylgermanium sesquioxide (Ge-132)].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cytotoxicity, Immunologic; Germanium; Leukemia, Experimental; Liver Neoplasms, Experimental; Macrophage Activation; Macrophages; Mice; Organometallic Compounds; Peritoneal Cavity; Propionates | 1985 |
[Antitumor effect in mice of an organic germanium compound (Ge-132) when different administration methods are used].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Drug Administration Schedule; Germanium; Infusions, Parenteral; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Organometallic Compounds; Propionates | 1985 |